Congratulations to our very own Lindsey Lyle, who received the MPN Hero Award for Commitment to the Individual at ASH on Friday, December 8th.
A salute to our patient, Jason Gallegos, leukemia survivor
Three case reports published in the New England Journal of Medicine demonstrate the promise of cancer immunotherapy in gray zone lymphoma, a rare subtype that mixes characteristics of Hodgkin and Non-Hodgkin forms of the disease.
University of Colorado Bone Marrow Transplant (BMT) Program outcomes are better than 90+% of programs in the United States when actual outcomes are compared to expected outcomes.
Tyler Buckner has been invited to join the prestigious Medical and Scientific Advisory Council (MASAC) of the National Hemophilia Foundation (NHF), an honor reserved for leaders in the field of Hemophilia and Bleeding Disorders.
May 23–Patient Power is hosting a live webinar, Living Well with MPNs, led by an expert panel who will discuss managing life with MPNs. You’ll hear advice for managing fatigue, itching, night sweats and other symptoms associated with MPN treatments.
The program at UCHealth University of Colorado Hospital once again achieves superior outcomes for vulnerable stem cell transplant patients.
DOM has selected 3 research groups to receive funding through its Team Science Program, designed to facilitate development or enhancement of collaborative research teams competitive for multi-investigator grant proposals and innovative new approaches.
Of the more than 1,000 manuscripts published in Blood, the Journal of the American Society of Hematology, 10 were selected as the most outstanding manuscripts of 2016. Drs Craig Jordan and Brett Stevens are contributing authors to a selected manuscript.
Manali Kamdar’s journey to specializing in the treatment of lymphomas with blood and marrow transplantation took nearly a decade. It all started in Mumbai, India with a little girl drawn to the arts and sciences.
The University of Colorado Division of Hematology will be hosting a review of the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in Denver on January 27, 2017.
Promising approach unleashes modified T-cells to battle acute lymphoblastic leukemia.
“If you’re working under a constant state of emergency, you become stressed and less effective. I think of blood stem cells in the same way,” Pietras says.
Dr. Daniel Sherbenou, MD, PhD, a recently recruited faculty member in the Hematology Division, was honored with a Young Investigator Award from the National Comprehensive Cancer Network (NCCN).
The morning of our first anniversary, I woke Stephanie up improvising the words to a song I'd just made up about bone marrow transplants. We then did the logical thing: recorded the song professionally.